![]() Edwards Lifesciences Edwards Lifesciences is a provider of patient-focused medical solutions for structural heart disease and critical care monitoring. | ![]() Glaukos Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. | ![]() Teleflex Teleflex Incorporated is a global provider of medical devices used in critical care and surgery. | ![]() ARTIVION CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. | ||
Founding Date | Founding Date 2015 | Founding Date 1958 | Founding Date 1998 | Founding Date 1943 | Founding Date 1984 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations London, GB HQ Dandenong South, AU Wien, AT Markham, CA Bogotá, CO Helsinki, FI Helsinki, FI see more | Locations Irvine, US HQ Macquarie Park, AU Wien, AT Dilbeek, BE São Paulo, BR Mississauga, CA Shanghai, CN see more | Locations Aliso Viejo, US HQ Buenos Aires, AR Heatherton, AU Sao Paulo, BR Richmond Hill, CA San José, CR Wiesbaden, DE see more | Locations Morrisville, US HQ Mascot, AU Markham, CA Lo Barnechea, CL Beijing, CN Shanghai, CN Bogotá, CO see more | Locations Kennesaw, US HQ Paris, FR Singapore, SG Guildford, GB Austin, US |
Employees | Employees 2,900 | Employees 15,80020% decrease | Employees 90716% increase | Employees 14,4005% decrease | Employees 1,2009% increase |
Valuation ($) | Valuation ($) 2.9 b | Valuation ($) 41.8 b | Valuation ($) 7.6 b | Valuation ($) 11.1 b | Valuation ($) 1.1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) $6.1b (FY, 2025) | Revenue (est.) $507.4m (FY, 2025) | Revenue (est.) $2b (FY, 2025) | Revenue (est.) $441.3m (FY, 2025) |
Cost of goods | Cost of goods $448.2m (FY, 2025) | Cost of goods $1.3b (FY, 2025) | Cost of goods $111.8m (FY, 2025) | Cost of goods $872m (FY, 2025) | Cost of goods $157.1m (FY, 2025) |
Gross profit | Gross profit $939.9m (FY, 2025) | Gross profit $4.7b (FY, 2025) | Gross profit $282.8m (FY, 2025) | Gross profit $1.1b (FY, 2025) | Gross profit $284.2m (FY, 2025) |
Net income | Net income ($242.5m) (FY, 2025) | Net income $1.1b (FY, 2025) | Net income ($187.7m) (FY, 2025) | Net income ($905.6m) (FY, 2025) | Net income $9.8m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 307.2m | Total funding raised $ 115m | Total funding raised $ 400m | Total funding raised $ 1.3m |

Edwards Lifesciences is a provider of patient-focused medical solutions for structural heart disease and critical care monitoring.
View company
Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases.
View company
Teleflex Incorporated is a global provider of medical devices used in critical care and surgery.
View company
CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair.
View company